Trials / Conditions / Amnestic Mild Cognitive Impairment

Amnestic Mild Cognitive Impairment

23 registered clinical trials studyying Amnestic Mild Cognitive Impairment — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Sleep Interventions and Neurocognitive Outcomes NCT05987007	New York State Psychiatric Institute	N/A
Recruiting	Modified Ketogenic Diet in Amnestic Mild Cognitive Impairments NCT06444568	Saglik Bilimleri Universitesi	N/A
Active Not Recruiting	Does Psilocybin Change Synaptic Density in Amnestic Mild Cognitive Impairment NCT06041152	Centre for Addiction and Mental Health	Phase 2
Recruiting	Training Response Artificial Intelligence Network (TRAIN) NCT05903573	University of Florida	N/A
Recruiting	MRI Guided Closed-loop TMS-EEG NCT06050603	Sunnybrook Health Sciences Centre	N/A
Recruiting	Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury History NCT05446584	University of Texas Southwestern Medical Center	Phase 2
Recruiting	Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia NCT04240561	Northwestern University	N/A
Completed	Noninvasive Brain Stimulation on Memory in Individuals With Mild Cognitive Impairment and History of Brain Inj NCT04504630	University of Texas Southwestern Medical Center	N/A
Unknown	COG-REAGENT: COGnitive tRaining in patiEnts With Amnestic Mild coGnitive impairmENT NCT04063956	Xuanwu Hospital, Beijing	N/A
Unknown	Interactive Stepping Exercise on Memory NCT04103463	National Yang Ming Chiao Tung University	N/A
Terminated	mSIM: Mobile Simultaneous Aerobic Exercise and Memory Training Intervention for Amnestic Mild Cognitive Impair NCT04185298	Jennifer Bramen	N/A
Completed	Sustainable Method for Alzheimer's Prediction NCT03654911	Catholic University of the Sacred Heart	—
Unknown	CTA-MCI: Cognitive Control Training in Patients With Amnestic Mild Cognitive Impairment(CTA-MCI) NCT03133052	First Affiliated Hospital of Zhejiang University	N/A
Completed	An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-893 NCT02910739	Merck Sharp & Dohme LLC	Phase 1
Completed	[18F]MK-6240 Positron Emission Tomography (PET) Tracer First-in-Human Validation Study (MK-6240-001) NCT02562989	Merck Sharp & Dohme LLC	Phase 1
Completed	The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) NCT01767909	University of Southern California	Phase 2 / Phase 3
Terminated	Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-893 NCT01953601	Merck Sharp & Dohme LLC	Phase 3
Completed	A Combined Training Program for Veterans With Amnestic Mild Cognitive Impairment NCT01962038	Palo Alto Veterans Institute for Research	N/A
Completed	Outcome Predictors of a Cognitive Intervention in aMCI NCT01525368	Ludwig-Maximilians - University of Munich	—
Terminated	Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impai NCT01072812	Annovis Bio Inc.	Phase 1
Completed	Brain Uptake and Safety With Probable Alzheimer's Disease, Amnestic Mild Cognitive Impairment and Healthy Volu NCT00785759	GE Healthcare	Phase 2
Completed	Recollection Training in Healthy Older Adults and Older Adults With Amnestic Mild Cognitive Impairment NCT00643266	Baycrest	N/A
Terminated	Effect of AQW051 in Patients With Memory Impairment NCT00582855	Novartis Pharmaceuticals	Phase 2